A case report on Mycobacterium houstonense infection after total hip arthroplasty.
Metagenomic next-generation sequencing
Mycobacteria houstonense
Periprosthetic joint Infection
Rapidly growing mycobacteria
Two-stage revision Surgery
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
25 Oct 2023
25 Oct 2023
Historique:
received:
05
03
2023
accepted:
12
10
2023
medline:
27
10
2023
pubmed:
26
10
2023
entrez:
25
10
2023
Statut:
epublish
Résumé
Mycobacterium houstonense is a category of rapidly growing mycobacteria that is gram-positive, acid-fast, polycrystalline, and non-spore-forming. There have been few reports of human infection caused by Mycobacterium houstonense worldwide. We present a case of chronic periprosthetic joint infection caused by Mycobacterium houstonense in an elderly female patient. The patient developed signs of infection after undergoing total hip arthroplasty. Despite receiving antibiotic treatment and revision surgery, the signs of infection recurred repeatedly. Multiple bacterial cultures during the treatment period were negative. Later, we identified the pathogenic bacteria Mycobacterium houstonense through mNGS testing, isolated the bacteria from the ultrasonically centrifuged fluid of the prosthesis and obtained drug sensitivity results. Finally, we performed a revision surgery and treated the patient with moxifloxacin and clindamycin. After treatment, the patient did not show signs of infection recurrence during 24 months of follow-up. Through a relevant literature search, we believe that Mycobacterium houstonense may show higher sensitivity to amikacin and quinolone antibiotics. Additionally, clarifying occult infection sources through methods such as gene testing will improve the diagnosis and treatment of periprosthetic joint infection.
Sections du résumé
BACKGROUND
BACKGROUND
Mycobacterium houstonense is a category of rapidly growing mycobacteria that is gram-positive, acid-fast, polycrystalline, and non-spore-forming. There have been few reports of human infection caused by Mycobacterium houstonense worldwide.
CASE PRESENTATION
METHODS
We present a case of chronic periprosthetic joint infection caused by Mycobacterium houstonense in an elderly female patient. The patient developed signs of infection after undergoing total hip arthroplasty. Despite receiving antibiotic treatment and revision surgery, the signs of infection recurred repeatedly. Multiple bacterial cultures during the treatment period were negative. Later, we identified the pathogenic bacteria Mycobacterium houstonense through mNGS testing, isolated the bacteria from the ultrasonically centrifuged fluid of the prosthesis and obtained drug sensitivity results. Finally, we performed a revision surgery and treated the patient with moxifloxacin and clindamycin. After treatment, the patient did not show signs of infection recurrence during 24 months of follow-up.
CONCLUSION
CONCLUSIONS
Through a relevant literature search, we believe that Mycobacterium houstonense may show higher sensitivity to amikacin and quinolone antibiotics. Additionally, clarifying occult infection sources through methods such as gene testing will improve the diagnosis and treatment of periprosthetic joint infection.
Identifiants
pubmed: 37880617
doi: 10.1186/s12879-023-08705-y
pii: 10.1186/s12879-023-08705-y
pmc: PMC10598912
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
722Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
J Clin Microbiol. 2016 Dec 28;55(1):234-243
pubmed: 27807152
Clin Infect Dis. 2008 Dec 1;47(11):1403-9
pubmed: 18937579
Indian J Orthop. 2013 Jan;47(1):10-7
pubmed: 23531512
Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416
pubmed: 17277290
Int J Syst Evol Microbiol. 2004 Sep;54(Pt 5):1653-1667
pubmed: 15388725
Front Cell Infect Microbiol. 2020 Sep 17;10:471
pubmed: 33042860
Clin Orthop Relat Res. 2005 Oct;439:27-31
pubmed: 16205133
Brief Bioinform. 2022 Mar 10;23(2):
pubmed: 35108376
J Arthroplasty. 2012 Sep;27(8 Suppl):61-5.e1
pubmed: 22554729
Front Microbiol. 2018 Jan 18;8:2651
pubmed: 29403446
Clin Orthop Relat Res. 2011 Apr;469(4):1002-8
pubmed: 20941647
Clin Orthop Relat Res. 2017 Jul;475(7):1837-1839
pubmed: 28488254
J Arthroplasty. 2022 Jun;37(6):1173-1179
pubmed: 35176456
EFORT Open Rev. 2021 Apr 1;6(4):236-244
pubmed: 34040801
J Clin Microbiol. 2016 Sep;54(9):2348-53
pubmed: 27413190
BMC Infect Dis. 2017 Dec 28;17(1):802
pubmed: 29281992
BMC Infect Dis. 2020 Nov 16;20(1):849
pubmed: 33198648
Am J Respir Crit Care Med. 2003 Mar 15;167(6):828-34
pubmed: 12433668
World J Orthop. 2022 May 18;13(5):503-514
pubmed: 35633748
Clin Chest Med. 2002 Sep;23(3):529-51
pubmed: 12370991
Open Orthop J. 2016 Nov 30;10:579-588
pubmed: 28144371
Bone Joint J. 2017 Nov;99-B(11):1490-1495
pubmed: 29092988
BMC Public Health. 2011 May 16;11:320
pubmed: 21575226
BMC Infect Dis. 2019 Apr 23;19(1):333
pubmed: 31014284
Clin Microbiol Infect. 2009 Oct;15(10):888-93
pubmed: 19845700
Microbiol Spectr. 2017 Jan;5(1):
pubmed: 28084211
Clin Infect Dis. 2018 Feb 10;66(5):778-788
pubmed: 29040428
Trends Microbiol. 2005 Jan;13(1):20-6
pubmed: 15639628
Clin Infect Dis. 2018 Oct 15;67(9):1333-1338
pubmed: 29648630
Front Neurol. 2022 Sep 01;13:908086
pubmed: 36119702
Clin Infect Dis. 2013 Jan;56(1):e1-e25
pubmed: 23223583
J Orthop. 2018 Mar 17;15(2):391-395
pubmed: 29881161